AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14760111 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (E) 25 mg once daily
Number of subjects: 122
Study 14760111 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (T) 20 mg once daily
Number of subjects: 122
Study 11142488 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (VER) 240 mg/day divided in 2 doses, from day 1 to day 28 of each cycle
Number of subjects: 99
Study 11142488 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VER)
Number of subjects: 99
Study 9187418 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg/day starting at day 3, increasing to 20 mg/day for 3 months
Number of subjects: 0
Study 9187418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1417492 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suture (polyglyconate, size 0)
Number of subjects: 340
Study 1417492 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suture (polyglactin 910, size 1)
Number of subjects: 340
Study 3883704 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 37
Study 3883704 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal education followed by SMBG
Number of subjects: 37
Study 3883704 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal education only
Number of subjects: 37
Study 3883704 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 37
Study 30824961 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intraperitoneal onlay mesh (Group A)
Number of subjects: 276
Study 30824961 — intervention group
Group type: COMPARATOR
Intervention: No additional mesh strip (Group B)
Number of subjects: 276
Study 29650336 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity with Blood Flow Restriction (LIBFR)
Number of subjects: 18
Study 29650336 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity (LI)
Number of subjects: 18
Study 29650336 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity (HI)
Number of subjects: 18
Study 27256153 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIMMER intervention (10-month combined dietary and physical activity intervention)
Number of subjects: 155
Study 27256153 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study 25275251 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan (OLM)
Number of subjects: 1513
Study 25275251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study 22160628 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC)
Number of subjects: 21
Study 22160628 — intervention group
Group type: COMPARATOR
Intervention: Standard Support Therapy (SST)
Number of subjects: 21
Study 20642391 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment at Week 8
Number of subjects: 267
Study 20642391 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment at 40 weeks
Number of subjects: 267
Study 20642391 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment at 8 weeks
Number of subjects: 267
Study 17977190 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet gel treatment
Number of subjects: 50
Study 17977190 — intervention group
Group type: COMPARATOR
Intervention: No platelet gel treatment (Control)
Number of subjects: 50
Study 16380361 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent education program presented on three audio CDs
Number of subjects: 846
Study 16380361 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 846
Study 12481953 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture for chronic headache
Number of subjects: 401
Study 12481953 — intervention group
Group type: COMPARATOR
Intervention: Retrospective recruitment methods
Number of subjects: 401
Study 9535315 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (450 mg at 150 mg three times per day, increased as needed)
Number of subjects: 15
Study 9535315 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (after stopping, lactose placebo administered for 3 weeks)
Number of subjects: 15
Study 9535315 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (second treatment)
Number of subjects: 15
Study 9535315 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine treatment
Number of subjects: 15
Study 8593197 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilized stannous fluoride dentifrice (Crest Gum Care)
Number of subjects: 16
Study 8593197 — intervention group
Group type: COMPARATOR
Intervention: Regular Crest dentifrice (NaF)
Number of subjects: 16
Study 8593197 — intervention group
Group type: COMPARATOR
Intervention: Commercial dentifrice containing SnF2
Number of subjects: 16
Study 2673476 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in controlled breathing
Number of subjects: 0
Study 2673476 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 1106746 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 21
Study 1106746 — intervention group
Group type: COMPARATOR
Intervention: Rimiterol
Number of subjects: 21
Study 1106746 — intervention group
Group type: COMPARATOR
Intervention: Combination of rimiterol and terbutaline
Number of subjects: 21
Study 31958772 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 24
Study 31958772 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study 31682205 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (ABT)
Number of subjects: 125
Study 31682205 — intervention group
Group type: COMPARATOR
Intervention: Pringle maneuver (PM)
Number of subjects: 125
Study 28552931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb loading symmetry training based on follow-up posturography with adaptively modified visual biofeedback
Number of subjects: 60
Study 28552931 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 60
Study 26846795 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose injections
Number of subjects: 30
Study 26846795 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study 24787499 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat breakfast
Number of subjects: 24
Study 24787499 — intervention group
Group type: COMPARATOR
Intervention: High protein breakfast
Number of subjects: 24
Study 24787499 — intervention group
Group type: COMPARATOR
Intervention: High carbohydrate breakfast
Number of subjects: 24
Study 24787499 — intervention group
Group type: COMPARATOR
Intervention: Balanced macronutrient breakfast
Number of subjects: 24
Study 21822735 — intervention group
Group type: EXPERIMENTAL
Intervention: Child HRQoL reports
Number of subjects: 222
Study 21822735 — intervention group
Group type: COMPARATOR
Intervention: Parent HRQoL reports
Number of subjects: 222
Study 21822735 — intervention group
Group type: EXPERIMENTAL
Intervention: Child and parent HRQoL agreement
Number of subjects: 222
Study 21822735 — intervention group
Group type: EXPERIMENTAL
Intervention: Social functioning
Number of subjects: 222
Study 21822735 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical functioning
Number of subjects: 222
Study 21822735 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQoL domain scores
Number of subjects: 222
Study 19700470 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg/day followed by 300 mg/day on day 15
Number of subjects: 429
Study 19700470 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg/day followed by 20 mg/day on day 15
Number of subjects: 429
Study 17479947 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir (400 mg per day or 300/100 mg per day with ritonavir)
Number of subjects: 419
Study 17479947 — intervention group
Group type: COMPARATOR
Intervention: Comparator PI regimen
Number of subjects: 419
Study 17479947 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir
Number of subjects: 419
Study 15543343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.2 mg to 0.4 mg daily for 12 weeks
Number of subjects: 38
Study 15543343 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 250 mg daily for 12 weeks
Number of subjects: 38
Study 12867500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracutaneous injection of endogenous PAR‐2 agonists
Number of subjects: 0
Study 12867500 — intervention group
Group type: COMPARATOR
Intervention: Local antihistamines
Number of subjects: 0
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy before irradiation
Number of subjects: 134
Study 10230458 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy after irradiation
Number of subjects: 134
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with contemporary positioning aids and individualized shielding techniques
Number of subjects: 134
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with linear accelerators
Number of subjects: 134
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with Cobalt machines
Number of subjects: 134
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy according to protocol guidelines
Number of subjects: 134
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with a gap between treatment fields
Number of subjects: 134
Study 10230458 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute neurotoxicity and skin reactions
Number of subjects: 134
Study 8721775 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance
Number of subjects: 524
Study 8721775 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance
Number of subjects: 524
Study 8721775 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly detected diabetes
Number of subjects: 524
Study 1826891 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ramipril
Number of subjects: 15
Study 1826891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6294770 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-cardiac arrest thiopental loading (30 mg/kg body wt)
Number of subjects: 0
Study 6294770 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 30623745 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage consumption
Number of subjects: 78
Study 30623745 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage consumption
Number of subjects: 78
Study 29725846 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% alpha-bisabolol mouthwash
Number of subjects: 30
Study 29725846 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine + 0.5% alpha-bisabolol mouthwash
Number of subjects: 30
Study 28546260 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation group (azathioprine/prednisolone to 48 months)
Number of subjects: 117
Study 28546260 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal group (withdraw azathioprine/prednisolone by 24 months)
Number of subjects: 117
Study 28546260 — intervention group
Group type: EXPERIMENTAL
Intervention: ANCA positivity at randomisation
Number of subjects: 117
Study 28546260 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation group
Number of subjects: 117
Study 28546260 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal group
Number of subjects: 117
Study 26930181 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 12
Study 24509407 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b (HDI) plus GM2-KLH/QS-1 (GMK)
Number of subjects: 794
Study 24509407 — intervention group
Group type: COMPARATOR
Intervention: GMK alone
Number of subjects: 794
Study 24509407 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b (HDI)
Number of subjects: 794
Study 24509407 — intervention group
Group type: COMPARATOR
Intervention: GMK (vaccine group)
Number of subjects: 794
Study 24509407 — intervention group
Group type: EXPERIMENTAL
Intervention: HDI-induced autoimmunity
Number of subjects: 794
Study 22491355 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 20
Study 22491355 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 20
Study 19171716 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous purged bone marrow transplantation (ABMT)
Number of subjects: 379
Study 19171716 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-retinoic acid (cis-RA)
Number of subjects: 379
Study 19171716 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 379
Study 19171716 — intervention group
Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 379
Study 19171716 — intervention group
Group type: EXPERIMENTAL
Intervention: ABMT/cis-RA
Number of subjects: 379
Study 19171716 — intervention group
Group type: COMPARATOR
Intervention: ABMT/no cis-RA
Number of subjects: 379
Study 19171716 — intervention group
Group type: COMPARATOR
Intervention: Continuing chemotherapy/cis-RA
Number of subjects: 379
Study 19171716 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy/no cis-RA
Number of subjects: 379
Study 17141772 — intervention group
Group type: EXPERIMENTAL
Intervention: Position changes during colonoscope withdrawal (left lateral for the cecum to the hepatic flexure, supine for the transverse colon, and right lateral for the splenic flexure and the descending colon)
Number of subjects: 14
Study 17141772 — intervention group
Group type: COMPARATOR
Intervention: Left lateral position only (without position changes)
Number of subjects: 14
Study 15860852 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 x 3 Gy
Number of subjects: 297
Study 15860852 — intervention group
Group type: COMPARATOR
Intervention: 2 x 8 Gy
Number of subjects: 297
Study 15860852 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 297
Study 15002538 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine-hydrochloride (18 g)
Number of subjects: 15
Study 9113543 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited tourniquet use for cementing time only
Number of subjects: 80
Study 9113543 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet use throughout the whole case
Number of subjects: 80
Study 9113543 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet use
Number of subjects: 80
Study 9113543 — intervention group
Group type: EXPERIMENTAL
Intervention: All tourniquet groups
Number of subjects: 80
Study 7510736 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (3 mg/kg)
Number of subjects: 8
Study 7510736 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 8
Study 3315761 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycaemia induced by insulin-glucose clamp technique (insulin: 2.4 mU/kg/min + glucose at variable rate) after an overnight fast
Number of subjects: 8
Study 3315761 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycaemia induced by insulin-glucose clamp technique after 72 hours fasting
Number of subjects: 8
Study 3315761 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting (72 hours)
Number of subjects: 8
Study 3315761 — intervention group
Group type: COMPARATOR
Intervention: Control study at normoglycaemia
Number of subjects: 8
Study 30793929 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-visualization (Group B, n = 165)
Number of subjects: 404
Study 30793929 — intervention group
Group type: COMPARATOR
Intervention: No self-visualization (Group A, n = 239)
Number of subjects: 404
Study 30793929 — intervention group
Group type: EXPERIMENTAL
Intervention: First cystoscopy (males)
Number of subjects: 404
Study 30793929 — intervention group
Group type: EXPERIMENTAL
Intervention: Third or more cystoscopy (males)
Number of subjects: 404
Study 30793929 — intervention group
Group type: EXPERIMENTAL
Intervention: First cystoscopy (females)
Number of subjects: 404
Study 30793929 — intervention group
Group type: EXPERIMENTAL
Intervention: Third or more cystoscopy (females)
Number of subjects: 404
Study 29504791 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting intervention
Number of subjects: 1238
Study 29504791 — intervention group
Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 1238
Study 29504791 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal only (n = 154, 13.8%)
Number of subjects: 1238
Study 29504791 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal only (n = 272, 24.3%)
Number of subjects: 1238
Study 29504791 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal and postnatal (n = 220, 19.7%)
Number of subjects: 1238
Study 29504791 — intervention group
Group type: EXPERIMENTAL
Intervention: No depressed mood on any assessment (n = 473, 42.3%)
Number of subjects: 1238
Study 27345636 — intervention group
Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus bendamustine
Number of subjects: 396
Study 27345636 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine monotherapy
Number of subjects: 396
Study 24117102 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 186
Study 24117102 — intervention group
Group type: COMPARATOR
Intervention: Formal Health Education (HE)
Number of subjects: 186
Study 22419151 — intervention group
Group type: COMPARATOR
Intervention: Acarbose test formulation (2×50 mg)
Number of subjects: 40
Study 18853144 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple aspiration test
Number of subjects: 20
Study 18853144 — intervention group
Group type: COMPARATOR
Intervention: Capnography
Number of subjects: 20
Study 17766766 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure self-help through written materials
Number of subjects: 224
Study 17766766 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented self-help (self-help augmented by five group sessions with a therapist)
Number of subjects: 224
Study 17766766 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 224
Study 17766766 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard, therapist-led group therapy
Number of subjects: 224
Study 15150679 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEXA) 2.0 mg
Number of subjects: 14
Study 15150679 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED) 12.5 mg
Number of subjects: 14
Study 15150679 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEXA)
Number of subjects: 14
Study 15150679 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED)
Number of subjects: 14
Study 15150679 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 14
Study 11219635 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 0
Study 11219635 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 0
Study 9919256 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video disk (IVD) system
Number of subjects: 0
Study 9919256 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary team support and information
Number of subjects: 0
Study 7820718 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel puncture (Autolet II Clinisafe)
Number of subjects: 47
Study 7820718 — intervention group
Group type: COMPARATOR
Intervention: Incision (Tenderfoot 'preemie')
Number of subjects: 47
Study 3277865 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG (1500 IU three times at 2-day intervals from the day of ET)
Number of subjects: 116
Study 3277865 — intervention group
Group type: COMPARATOR
Intervention: Control (no hCG support)
Number of subjects: 116
Study 1562888 — intervention group
Group type: EXPERIMENTAL
Intervention: Distensive arthrography with intra-articular corticosteroids
Number of subjects: 45
Study 1562888 — intervention group
Group type: COMPARATOR
Intervention: Nondistensive arthrography with intra-articular corticosteroids
Number of subjects: 45
Study 1562888 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (distensive and nondistensive)
Number of subjects: 45
Study 354827 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-methyldopa up to 500 mg b.i.d.
Number of subjects: 110
Study 354827 — intervention group
Group type: COMPARATOR
Intervention: metoprolol up to 200 mg b.i.d.
Number of subjects: 110
Study 30423468 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (DVLX)
Number of subjects: 71
Study 30423468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 28760403 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate androgen-deprivation therapy
Number of subjects: 293
Study 28760403 — intervention group
Group type: COMPARATOR
Intervention: Delayed androgen-deprivation therapy
Number of subjects: 293
Study 25681236 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 30
Study 25681236 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 30
Study 23900457 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated interferon-α2a
Number of subjects: 150
Study 20821373 — intervention group
Group type: EXPERIMENTAL
Intervention: PST-OT (Problem-solving and Occupational Therapy intervention)
Number of subjects: 31
Study 20821373 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 31
Study 19016254 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Utilities Index (HUI)-III
Number of subjects: 421
Study 19016254 — intervention group
Group type: EXPERIMENTAL
Intervention: AD-Related Quality of Life Scale (ADRQoL)
Number of subjects: 421
Study 17074350 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS concentrations in PCOS probands
Number of subjects: 131
Study 17074350 — intervention group
Group type: EXPERIMENTAL
Intervention: Sister-sister correlation of DHEAS levels
Number of subjects: 131
Study 17074350 — intervention group
Group type: EXPERIMENTAL
Intervention: Heritability (h²) of DHEAS levels
Number of subjects: 131
Study 15080354 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemomechanical Carisolv method
Number of subjects: 0
Study 15080354 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical method
Number of subjects: 0